-
-
-
-
-
-
-
NurExone Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NephroGenex (NRX) to Pause Clinical Program of Product Candidate Oral Pyridorin for Treatment of Diabetic Nephropathy
-
-
-
-
-
-
-
Trading Radar for 11/11: Macy's (M), NetEase (NTES), Digital Ally (DGLY), Elbit Systems (ESLT) Report
-
-
-
-
-
-
-
NephroGenex Reports First Quarter 2015 Financial Results
-
-
-
-
-
-
-
NephroGenex to Host Conference Call on Fourth Quarter and Full Year 2014 Financial Results on Wednesday, March 25, 2015
-
-
-
-
-
1,224,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

